SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories informs about press release

29 Jan 2016 Evaluate

Unichem Laboratories has informed about a press release dated January 29, 2016 titled ‘Unichem Laboratories receives Final ANDA approval from USFDA for Alfuzosin Hydrochloride Extended-Release Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Unichem Laboratories Share Price

476.60 12.20 (2.63%)
01-Jul-2026 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1873.60
Dr. Reddys Labs. 1343.05
Cipla 1458.05
Zydus Lifesciences 1107.85
Lupin 2400.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: